Heparin-coated Cardiopulmonary Bypass Circuits Reduce Circulating Complement Factors and Interleukin-6 in Paediatric Heart Surgery

By Olsson Christian   Siegbahn Agneta   Henze Axel   Nilsson Bo   Venge Per   Joachimsson Per-Olof   Thelin Stefan  

Scandinavian Cardiovascular Journal, Vol. 34, Iss. 1, 2000-05 ,pp. : 33-40

Informa Healthcare

Access to resources Recommend Favorite

Heparin, Platelet Aggregation, Neutrophils, and Cardiopulmonary Bypass

By Belcher P.R.   Muriithi E.W.   Milne E.M.   Wanikiat P.   Wheatley D.J.   Armstrong R.A.  

Thrombosis Research, Vol. 98, Iss. 4, 2000-05 ,pp. : 249-256

Elsevier

Access to resources Recommend Favorite

Platelet dysfunction, platelet function tests and cardiopulmonary bypass with heparin anticoagulation

By Muriithi E.W.   Belcher P.R.   Menys V.C.  

Thrombosis Research, Vol. 107, Iss. 1, 2002-07 ,pp. : 81-82

Elsevier

Access to resources Recommend Favorite

Bivalirudin: Alternative Anticoagulation During Cardiopulmonary Bypass in Patients with Heparin-Induced Thrombocytopenia

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 20-24

Bentham Science Publishers

Access to resources Recommend Favorite

Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting

By Koster A.   Spiess B.   Chew D.P.   Krabatsch T.   Tambeur L.   DeAnda A.   Hetzer R.   Kuppe H.   Smedira N.G.   Lincoff A.M.  

The American Journal of Cardiology, Vol. 93, Iss. 3, 2004-02 ,pp. : 356-359

Elsevier

Access to resources Recommend Favorite